When considering what names to put on your watch list, look for stocks with an 80 or higher RS Rating. Axsome Therapeutics now meets that criteria, with an increase from 80 to 86 Tuesday.
As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.
This exclusive rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains often have an RS Rating north of 80 as they launch their biggest price moves.
Looking For The Best Stocks To Buy And Watch? Start Here
While Axsome Therapeutics is not near a proper buy zone right now, see if it goes on to form and break out of a proper consolidation.
Axsome Therapeutics reported 0% earnings growth last quarter, while sales growth came in at 429%.
Axsome Therapeutics earns the No. 126 rank among its peers in the Medical-Biomed/Biotech industry group. Kiniksa Pharmaceuticals and Catalyst Pharmaceuticals are also among the group's highest-rated stocks.
